
Alameda, California-based medtech startup Science has raised $400 million in a Series D funding round. The company develops technology in the medical and healthcare sector and will use the investment to support its growth and development.
The funding round attracted several investors, including Khosla Ventures, Ackman Oxman Institute, Tenet Healthcare, 885 Capital, Y Combinator and PLC Neurotech.
The company will use the funding to make its PRIMA technology available to more people across Europe. It also plans to prepare for its launch in the United States through the FDA’s Humanitarian Device Exemption pathway.
The company will also invest in expanding its research, manufacturing facilities and daily operations to support its future growth.
Founded by CEO Max Hodak, Science Corporation develops brain-computer technology to help people regain their vision and treat brain-related conditions. Its main product, PRIMA, is a small implant placed under the retina and used with special camera glasses to help restore the ability to see shapes and objects.
The company is also working on another technology that combines specially developed nerve cells with the brain’s natural connections. This approach aims to help the brain work with the new cells.